Northern Trust’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Northern Trust’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-239,460	Closed	-$8.61M	–	4528
2020 Q4	$8.61M	Sell	239,460 -6,130	-2%	-$215K	﹤0.01%	2342
2020 Q3	$6.9M	Buy	245,590 +7,762	+3%	+$275K	﹤0.01%	2336
2020 Q2	$10.3M	Buy	237,828 +149,844	+170%	+$6.78M	﹤0.01%	2074
2020 Q1	$3.34M	Buy	87,984 +434	+0.5%	+$16.9K	﹤0.01%	2545
2019 Q4	$2.38M	Buy	+87,550	New	+$2.21M	﹤0.01%	3015

Northern Trust's VIE Position: Q1 2021 in Review

Northern Trust sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 239,460 shares — an estimated $8.61M sold.

Northern Trust first reported a position in VIE in Q4 2019 and held it in 5 quarters. The position peaked at $10.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Northern Trust reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Northern Trust sold 239,460 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $8.61M.
Northern Trust first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Northern Trust's Viela Bio, Inc. Common Stock position peaked at $10.3M in Q2 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Northern Trust's 13F filing for Q1 2021, filed 12 May 2021.